- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
North Chicago Today
By the People, for the People
Banque Pictet & Cie SA Increases Stake in AbbVie Inc.
The Swiss bank's holdings in the pharmaceutical company now exceed $88 million.
Apr. 2, 2026 at 7:34am
Got story updates? Submit your updates here. ›
Banque Pictet & Cie SA, a Swiss private bank, has increased its stake in AbbVie Inc. (NYSE: ABBV) by 16.5% during the fourth quarter, according to a recent SEC filing. The bank now owns 388,924 shares of the pharmaceutical company's stock, valued at $88.87 million.
Why it matters
This investment signals Banque Pictet & Cie SA's confidence in AbbVie's long-term growth potential. As a major institutional investor, the bank's increased stake could influence other investors' perceptions of AbbVie's stock.
The details
According to the filing, Banque Pictet & Cie SA purchased an additional 54,953 shares of AbbVie during the fourth quarter, bringing its total holdings to 388,924 shares. This represents a 16.5% increase in the bank's position in the company. AbbVie accounts for 0.5% of Banque Pictet & Cie SA's total investment portfolio, making it the 21st largest holding.
- Banque Pictet & Cie SA increased its stake in AbbVie during the fourth quarter of 2025.
The players
Banque Pictet & Cie SA
A Swiss private bank that has increased its investment in AbbVie Inc.
AbbVie Inc.
A global biopharmaceutical company that develops and commercializes therapies for complex and chronic medical conditions.
The takeaway
Banque Pictet & Cie SA's increased stake in AbbVie suggests the bank's confidence in the pharmaceutical company's long-term growth prospects. This investment could signal a positive outlook for AbbVie's stock among institutional investors.
